A public consultation on the review of the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry has received a strong response.

 

​Some 21 professional bodies, patient advocacy groups, healthcare campaigning organisations and private individuals took part in the process by sharing their views on a range of issues. These included:

  • The effectiveness of the code, including complaints, sanctions and procedures
  • The code's relevance to the current NHS
  • How the code might be updated/improved
  • Awareness and use of the code by the NHS, public and industry
  • The quality of promotional activity by the pharmaceutical industry

The ABPI Code of Practice covers pharmaceutical company promotion of prescription medicines to UK healthcare professionals in the UK and the provision of information to the public. It aims to safeguard the interests of patients and to ensure a responsible and ethical approach to such activities. Established in 1958 the Code is frequently updated. The last review in 2002 resulted in the current 2003 edition of the code. In addition, there are periodical full reviews - the current is the first since 1993.

The consultation submissions will be analysed by the review team over the next few weeks and the full review process is expected to reach completion by the end of 2005.

For further information, please contact: ABPI Press Office 020 7747 1410

 
Print this page icon Print this page
 
Please choose the subject of your enquiry from the list below:
 
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.